These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 6127353

  • 1. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B.
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [Abstract] [Full Text] [Related]

  • 2. Tardive dyskinesia: a review and current treatment options.
    Najib J.
    Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647
    [Abstract] [Full Text] [Related]

  • 3. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
    Pourcher E, Cohen H, Cohen D, Baruch P, Bouchard RH.
    Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
    [Abstract] [Full Text] [Related]

  • 4. Early course of new-onset tardive dyskinesia in older patients.
    Lacro JP, Gilbert PL, Paulsen JS, Fell R, Bailey A, Juels C, Caligiuri M, McAdams LA, Harris MJ, Jeste DV.
    Psychopharmacol Bull; 1994 Sep; 30(2):187-91. PubMed ID: 7831454
    [Abstract] [Full Text] [Related]

  • 5. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
    Glazer WM, Morgenstern H, Doucette JT.
    J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
    [Abstract] [Full Text] [Related]

  • 6. Tardive dyskinesia in outpatients on depot phenothiazine.
    Neehall J.
    West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
    [Abstract] [Full Text] [Related]

  • 7. The natural history of tardive dyskinesia.
    Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore P.
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
    [Abstract] [Full Text] [Related]

  • 8. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM, Woerner M, Lieberman J.
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):52S-56S. PubMed ID: 3065365
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 10. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
    Kovacic B, Domino EF.
    J Clin Psychopharmacol; 1982 Oct; 2(5):305-7. PubMed ID: 6890075
    [Abstract] [Full Text] [Related]

  • 11. Preliminary findings with regard to risk factors in the development of tardive dyskinesia [proceedings].
    Kane J, Struve F, Woerner M, Weinhold P.
    Psychopharmacol Bull; 1981 Jan; 17(1):47-9. PubMed ID: 6112775
    [No Abstract] [Full Text] [Related]

  • 12. An electroencephalographic study of psychiatric inpatients with antipsychotic-induced tardive dyskinesia.
    Koshino Y, Hiramatsu H, Isaki K, Yamaguchi N.
    Clin Electroencephalogr; 1986 Jan; 17(1):30-5. PubMed ID: 2869843
    [Abstract] [Full Text] [Related]

  • 13. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM, Annable L, Bélanger MC, Chouinard G.
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [Abstract] [Full Text] [Related]

  • 14. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK, Miller DD, Arndt S, Ziebell S, Gupta S, Andreasen NC.
    Biol Psychiatry; 1995 Dec 01; 38(11):713-9. PubMed ID: 8580223
    [Abstract] [Full Text] [Related]

  • 15. [Tardive dyskinesia: a review].
    Crespo Facorro B, Payá González B, Ruiz Fernández V, Carbonell Masia C.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997 Dec 01; 25(2):118-27. PubMed ID: 9245189
    [Abstract] [Full Text] [Related]

  • 16. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL, Kelly MW.
    Am J Hosp Pharm; 1994 Apr 01; 51(7):895-9. PubMed ID: 7912473
    [Abstract] [Full Text] [Related]

  • 17. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
    Damier P, Thobois S, Witjas T, Cuny E, Derost P, Raoul S, Mertens P, Peragut JC, Lemaire JJ, Burbaud P, Nguyen JM, Llorca PM, Rascol O, French Stimulation for Tardive Dyskinesia (STARDYS) Study Group.
    Arch Gen Psychiatry; 2007 Feb 01; 64(2):170-6. PubMed ID: 17283284
    [Abstract] [Full Text] [Related]

  • 18. Handedness and the risk of tardive dyskinesia.
    Morgenstern H, Glazer WM, Doucette JT.
    Biol Psychiatry; 1996 Jul 01; 40(1):35-42. PubMed ID: 8780853
    [Abstract] [Full Text] [Related]

  • 19. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM.
    J Clin Psychiatry; 2000 Jul 01; 61 Suppl 4():15-20. PubMed ID: 10739326
    [Abstract] [Full Text] [Related]

  • 20. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug 01; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.